Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Aug 04, 2021 6:54pm
203 Views
Post# 33652492

RE:Posting for a new COO and Clinical Trial Coordinator

RE:Posting for a new COO and Clinical Trial CoordinatorThat's very interesting. The ad for the Chief Operating Officer – Cool Laser Therapy Division says:

"The COO will be responsible for:
 
1) Primary – Triple digit revenue growth of the Company’s current medical devices.

2) Secondary – Research, development, regulatory approval and successful launch of the Company’s new medical devices
 
The COO will manage their team through the daily execution and weekly follow-up of a detailed medical device revenue growth strategy, focused on revenue growth."

Revenue for 2020 was $815,159, so the mandate for the new COO is to increase annual revenue to at least $1,630,318. 


z_investor wrote: Just saw this on Indeed.

Clinical Study Coordinator
Theralase Technologies Inc. - Toronto, ON
$75,000 a year
The Anti-Cancer Therapy (“*ACT*”) division, which is a clinical stage, pre-commercialization research and development division dedicated to the research and…
Easily apply
3-Aug
Chief Operating Officer (COO)
Theralase Technologies Inc. - Toronto, ON
$250,000 a year
The Anti-Cancer Therapy (“*ACT*”) division, which is a clinical stage, pre-commercialization research and development division dedicated to the research and…
Easily apply
3-Aug



<< Previous
Bullboard Posts
Next >>